Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,090 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-Wide Association Study Identifies Two Common Loci Associated with Pigment Dispersion Syndrome/Pigmentary Glaucoma and Implicates Myopia in its Development.
Simcoe MJ, Shah A, Fan B, Choquet H, Weisschuh N, Waseem NH, Jiang C, Melles RB, Ritch R, Mahroo OA, Wissinger B, Jorgenson E, Wiggs JL, Garway-Heath DF, Hysi PG, Hammond CJ. Simcoe MJ, et al. Among authors: shah a. Ophthalmology. 2022 Jun;129(6):626-636. doi: 10.1016/j.ophtha.2022.01.005. Epub 2022 Jan 11. Ophthalmology. 2022. PMID: 35031440 Free article.
The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
Lascaratos G, Garway-Heath DF, Burton R, Bunce C, Xing W, Crabb DP, Russell RA, Shah A; United Kingdom Glaucoma Treatment Study Group. Lascaratos G, et al. Among authors: shah a. Ophthalmology. 2013 Dec;120(12):2540-2545. doi: 10.1016/j.ophtha.2013.07.054. Epub 2013 Oct 11. Ophthalmology. 2013. PMID: 24126032 Clinical Trial.
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.
Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, Suzuki K, White ET, Wormald RP, Xing W, Zeyen TG. Garway-Heath DF, et al. Among authors: shah a. Lancet. 2015 Apr 4;385(9975):1295-304. doi: 10.1016/S0140-6736(14)62111-5. Epub 2014 Dec 19. Lancet. 2015. PMID: 25533656 Free article. Clinical Trial.
Mutations in SPATA13/ASEF2 cause primary angle closure glaucoma.
Waseem NH, Low S, Shah AZ, Avisetti D, Ostergaard P, Simpson M, Niemiec KA, Martin-Martin B, Aldehlawi H, Usman S, Lee PS, Khawaja AP, Ruddle JB, Shah A, Sackey E, Day A, Jiang Y, Swinfield G, Viswanathan A, Alfano G, Chakarova C, Cordell HJ, Garway-Heath DF, Khaw PT, Bhattacharya SS, Waseem A, Foster PJ. Waseem NH, et al. Among authors: shah az, shah a. PLoS Genet. 2020 Apr 27;16(4):e1008721. doi: 10.1371/journal.pgen.1008721. eCollection 2020 Apr. PLoS Genet. 2020. PMID: 32339198 Free PMC article.
OCT Signal Enhancement with Deep Learning.
Lazaridis G, Lorenzi M, Mohamed-Noriega J, Aguilar-Munoa S, Suzuki K, Nomoto H, Ourselin S, Garway-Heath DF; United Kingdom Glaucoma Treatment Study Investigators. Lazaridis G, et al. Ophthalmol Glaucoma. 2021 May-Jun;4(3):295-304. doi: 10.1016/j.ogla.2020.10.008. Epub 2020 Oct 15. Ophthalmol Glaucoma. 2021. PMID: 33069883 Clinical Trial.
12,090 results
You have reached the last available page of results. Please see the User Guide for more information.